Gentler risedronate forms patented by P&G
Procter & Gamble has patented a new formulation of risedronate that overcomes the upper gastrointestinal side effects that can occur with the osteoporosis drug.
Procter & Gamble has patented a new formulation of risedronate that overcomes the upper gastrointestinal side effects that can occur with the osteoporosis drug.
Baxter has filed a lawsuit in the USA alleging that one of its former employees provided proprietary manufacturing information to rival company Bayer.
LGC has acquired Germany's Mikromol, a specialist in pharmaceutical impurities and metabolites used as reference materials, to create its first non-UK lab.
Neo Pharma becomes the first company to start manufacturing pharmaceuticals in Abu Dhabi. The company's facility offers both production and R&D capabilities.
Australian dairy farmers could become major suppliers of pharmaceutical-grade lactose, if a new technology developed at the Commonwealth Scientific and Industrial Research Organisation can be exploited commercially.